Skip to main content

Vera Therapeutics, Inc. insider trading

VERANASDAQ
$29.42-0.41 (-1.37% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 6, 2026. Price (-4.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flow

Key players

  • PGPatrick G. EnrightDirector7.5679%of company
  • MFMarshall FordycePRESIDENT AND CEO0.3297%of company
  • BCBeth C. SeidenbergDirector0.19%of company
  • SGSean GrantCHIEF FINANCIAL OFFICER0.167%of company
  • JRJoseph R. YoungSVP, FINANCE, CHIEF ACCT OFFCR0.1132%of company
  • LMLaurence Matthew SkeltonChief Commercial Officer0.09%of company
  • RBRobert BrennerChief Medical Officer0.0714%of company
  • JSJason S. CarterChief Legal Officer0.0689%of company
  • DLDavid Lee JohnsonChief Operating Officer0.0641%of company
  • WDWilliam D. TurnerChief Regulatory Officer0.0635%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
VERAMarshall FordycePRESIDENT AND CEOOpen market sell$41K-0.2%$45.51$41KApr 14, 2026Apr 15, 2026
VERAMarshall FordycePRESIDENT AND CEOOpen market sell$353K-1.7%$44.58$353KApr 14, 2026Apr 15, 2026
VERAMarshall FordycePRESIDENT AND CEOOpen market sell$617K-2.9%$43.66$617KApr 14, 2026Apr 15, 2026
VERALaurence Matthew SkeltonChief Commercial OfficerOpen market sell$66.4K-2.4%$41.98$66.4KFeb 23, 2026Feb 25, 2026
VERARobert BrennerChief Medical OfficerOpen market sell$90.3K-4.1%$41.98$90.3KFeb 23, 2026Feb 25, 2026
VERASean GrantCHIEF FINANCIAL OFFICEROpen market sell$208K-4.0%$41.98$208KFeb 23, 2026Feb 25, 2026
VERAJoseph R. YoungSVP, FINANCE, CHIEF ACCT OFFCROpen market sell$131K-4.6%$41.98$131KFeb 23, 2026Feb 25, 2026
VERAMarshall FordycePRESIDENT AND CEOOpen market sell$711K-3.4%$41.98$711KFeb 23, 2026Feb 25, 2026
VERAWilliam D. TurnerChief Regulatory OfficerOpen market sell$91.8K-4.6%$41.98$91.8KFeb 23, 2026Feb 25, 2026
VERADavid Lee JohnsonChief Operating OfficerOpen market sell$108K-5.3%$41.98$108KFeb 23, 2026Feb 25, 2026
VERAPatrick G. EnrightDirectorOpen market purchase$250K+0.2%$42.50$250KDec 11, 2025Dec 15, 2025
VERAJason S. CarterChief Legal OfficerOpen market sell$107K-7.3%$27.82$107KNov 21, 2025Nov 25, 2025
VERAJoseph R. YoungSVP, FINANCE, CHIEF ACCT OFFCROpen market sell$436K-23.9%$29.06$436KNov 11, 2025Nov 13, 2025
End of history · 13 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.